cell signaling technology 9139 (Cell Signaling Technology Inc)
97
Structured Review
Cell Signaling Technology Inc
cell signaling technology 9139
Cell Signaling Technology 9139, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 3319 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+signaling+technology+9139/Stat3+Mouse+mAb/pm41882003-400-46-46
Average 97 stars, based on 3319 article reviews
Cell Signaling Technology 9139, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 3319 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+signaling+technology+9139/Stat3+Mouse+mAb/pm41882003-400-46-46
Average 97 stars, based on 3319 article reviews
cell signaling technology 9139 - by Bioz Stars,
2026-09
97/100 stars
Images
Related Articles
Immunohistochemistry:Article Title: Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness. Article Snippet: The following antibodies are used for immunoblotting (IB), immunoprecipitation (IP), immunohistochemistry (IHC), immunofluorescence (IF) and Chromatin immunoprecipitation (ChIP) assay in this study: PSMD14, Proteintech (Rosemont, IL, USA), 12059-1-AP (IB, 1:1000); PSMD14, Sigma-Aldrich (St. Louis, MO, USA), HPA002114 (IHC, 1:400); PSMD14, Santa Cruz (Dallas, Texas, USA), sc-100464 (IF, 1:200); PARP, Cell Signaling Technology (Danvers, MA, USA), #9542 (IB, 1:1000); Caspase-3, Abcam (Cambridge, UK), ab32351 (IB, 1:1000); Cleaved Caspase-3, Cell Signaling Technology, #9661 (IHC, 1:400); SOX2, Proteintech, Theranostics 2021, Vol. .. 11, Issue 6 http://www.thno.org 2657 11064-1-AP (IB, 1:1000; IF, 1:200; IHC, 1:200); Akt, Cell Signaling Technology, #4685 (IB, 1:1000); Phospho-Akt (Ser473), Cell Signaling Technology, #4060 (IB, 1:1000); E2F1, Abcam, ab179445 (IB, 1:1000; IP, 1:100; IHC, 1:200; ChIP, 1:500); Ubiquitin, Cell Signaling Technology, #3936 (IB, 1:1000); Ki67, Cell Signaling Technology, #9449 (IHC, 1:500); Erk1/2, Cell Signaling Technology, #4695 (IB, 1:1000); Phospho-Erk1/2 (Thr202/Tyr204), Cell Signaling Technology, #4370 (IB, 1:1000); Chromatin Immunoprecipitation:Article Title: Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness. Article Snippet: The following antibodies are used for immunoblotting (IB), immunoprecipitation (IP), immunohistochemistry (IHC), immunofluorescence (IF) and Chromatin immunoprecipitation (ChIP) assay in this study: PSMD14, Proteintech (Rosemont, IL, USA), 12059-1-AP (IB, 1:1000); PSMD14, Sigma-Aldrich (St. Louis, MO, USA), HPA002114 (IHC, 1:400); PSMD14, Santa Cruz (Dallas, Texas, USA), sc-100464 (IF, 1:200); PARP, Cell Signaling Technology (Danvers, MA, USA), #9542 (IB, 1:1000); Caspase-3, Abcam (Cambridge, UK), ab32351 (IB, 1:1000); Cleaved Caspase-3, Cell Signaling Technology, #9661 (IHC, 1:400); SOX2, Proteintech, Theranostics 2021, Vol. .. 11, Issue 6 http://www.thno.org 2657 11064-1-AP (IB, 1:1000; IF, 1:200; IHC, 1:200); Akt, Cell Signaling Technology, #4685 (IB, 1:1000); Phospho-Akt (Ser473), Cell Signaling Technology, #4060 (IB, 1:1000); E2F1, Abcam, ab179445 (IB, 1:1000; IP, 1:100; IHC, 1:200; ChIP, 1:500); Ubiquitin, Cell Signaling Technology, #3936 (IB, 1:1000); Ki67, Cell Signaling Technology, #9449 (IHC, 1:500); Erk1/2, Cell Signaling Technology, #4695 (IB, 1:1000); Phospho-Erk1/2 (Thr202/Tyr204), Cell Signaling Technology, #4370 (IB, 1:1000); Ubiquitin Proteomics:Article Title: Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness. Article Snippet: The following antibodies are used for immunoblotting (IB), immunoprecipitation (IP), immunohistochemistry (IHC), immunofluorescence (IF) and Chromatin immunoprecipitation (ChIP) assay in this study: PSMD14, Proteintech (Rosemont, IL, USA), 12059-1-AP (IB, 1:1000); PSMD14, Sigma-Aldrich (St. Louis, MO, USA), HPA002114 (IHC, 1:400); PSMD14, Santa Cruz (Dallas, Texas, USA), sc-100464 (IF, 1:200); PARP, Cell Signaling Technology (Danvers, MA, USA), #9542 (IB, 1:1000); Caspase-3, Abcam (Cambridge, UK), ab32351 (IB, 1:1000); Cleaved Caspase-3, Cell Signaling Technology, #9661 (IHC, 1:400); SOX2, Proteintech, Theranostics 2021, Vol. .. 11, Issue 6 http://www.thno.org 2657 11064-1-AP (IB, 1:1000; IF, 1:200; IHC, 1:200); Akt, Cell Signaling Technology, #4685 (IB, 1:1000); Phospho-Akt (Ser473), Cell Signaling Technology, #4060 (IB, 1:1000); E2F1, Abcam, ab179445 (IB, 1:1000; IP, 1:100; IHC, 1:200; ChIP, 1:500); Ubiquitin, Cell Signaling Technology, #3936 (IB, 1:1000); Ki67, Cell Signaling Technology, #9449 (IHC, 1:500); Erk1/2, Cell Signaling Technology, #4695 (IB, 1:1000); Phospho-Erk1/2 (Thr202/Tyr204), Cell Signaling Technology, #4370 (IB, 1:1000); other:Article Title: Hypoxia-induced miR-5100 promotes exosome-mediated activation of cancer-associated fibroblasts and metastasis of head and neck squamous cell carcinoma. Article Snippet: The following antibodies are used for immunohistochemistry (IHC), immunoblotting (IB), immunofluorescence (IF) and Chromatin immunoprecipitation (ChIP) assay in this study: HIF1α, Abcam (Cambridge, UK), ab51608 (IB, 1:1000; IHC, 1:400); α-SMA, Abcam, ab7817 (IB, 1:1000; IHC, 1:400; IF, 1:200); E-Cadherin, Proteintech (Rosemont, IL, USA), 60335-1-1 g (IB, 1:1000; IHC, 1:150); N-Cadherin, Proteintech, 22018-1-AP (IB, 1:1000; IHC, 1:200); Vimentin, Cell Signaling Technology (Danvers, MA, USA), #5641 (IB, 1:1000); Zeb1, Proteintech, 21544-1-AP (IB, 1:1000); Snail, Cell Signaling Technology, #3879 (IB, 1:1000); Slug, Cell Signaling Technology, #9585 (IB, 1:1000); Twist, Abcam, ab50581 (IB, 1:1000); QKI, Proteintech, 13169-1-AP (IB,1:1000; IHC, 1:400); ALIX, Santa Cruz (Dallas, Texas, USA), sc-53540 (IB, 1:1000); CD63, Santa Cruz, sc-5275 (IB, 1:1000); CD9, Santa Cruz, sc-13118 (IB, 1:500); AKT, Cell Signaling Technology, #4685 (IB, 1:1000); Phospho-AKT (Ser473), Cell Signaling Technology, #4060 (IB, 1:1000; IHC, 1:300); STAT3, Article Title: Extracellular matrix rigidity controls breast cancer metastasis via TYK2-mediated mechanotransduction. Article Snippet: Antibodies were conjugated to protein G beads (LYN) or protein A beads (TYK2) (Invitrogen), crosslinked using disuccinimidyl suberate (Pierce) as per manufacturer’s protocol, incubated with lysates overnight at 4°C, washed eight times with IP lysis buffer supplemented with 200 mM NaCl, and eluted by incubation in LDS sample buffer with 50 mM DTT at 70°C for 10 minutes. |